Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | siRNA-EphA2-DOPC |
| Synonyms | |
| Therapy Description |
siRNA-EphA2-DOPC comprises liposome-encapsulated EphA2 targeting small-interfering RNA (siRNA), which inhibits EphA2 expression, potentially resulting in decreased tumor growth (PMID: 16061675). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| siRNA-EphA2-DOPC | siRNA-EphA2-DOPC comprises liposome-encapsulated EphA2 targeting small-interfering RNA (siRNA), which inhibits EphA2 expression, potentially resulting in decreased tumor growth (PMID: 16061675). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT01591356 | Phase I | siRNA-EphA2-DOPC | EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors | Active, not recruiting | USA | 0 |